medroxyprogesterone injection / Generic mfg.  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
medroxyprogesterone injection / Generic mfg.
NCT00830414: Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Completed
1
124
Europe
medroxyprogesterone acetate, DEPO-PROVERA®
Teva Pharmaceuticals USA
Healthy
09/02
09/02
NCT03700658: A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046

Completed
1
27
RoW
TV-46046, Depo-subQ 104, Medroxyprogesterone acetate injectable suspension, Depo-subQ Provera 104®, TV-46046 Placebo
Teva Branded Pharmaceutical Products R&D, Inc., FHI 360
Contraception
10/20
10/20

Download Options